Nuveen’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-131,695
Closed -$4.49M 3368
2024
Q2
$4.49M Buy
131,695
+4,993
+4% +$148K ﹤0.01% 2006
2024
Q1
$4.46M Buy
126,702
+310
+0.2% +$10.4K ﹤0.01% 2046
2023
Q4
$3.65M Buy
126,392
+14,293
+13% +$340K ﹤0.01% 2116
2023
Q3
$2.57M Sell
112,099
-104,098
-48% -$5.46M ﹤0.01% 2198
2023
Q2
$12.4M Sell
216,197
-106,964
-33% -$5.59M ﹤0.01% 1375
2023
Q1
$12.2M Sell
323,161
-14,675
-4% -$541K ﹤0.01% 1361
2022
Q4
$9.04M Buy
337,836
+103,430
+44% +$2.83M ﹤0.01% 1560
2022
Q3
$6.63M Buy
234,406
+158,042
+207% +$4.41M ﹤0.01% 1725
2022
Q2
$1.66M Buy
76,364
+9,644
+14% +$269K ﹤0.01% 2532
2022
Q1
$2.87M Sell
66,720
-564
-0.8% -$23.6K ﹤0.01% 2345
2021
Q4
$2.92M Sell
67,284
-5,536
-8% -$297K ﹤0.01% 2382
2021
Q3
$4.92M Sell
72,820
-47,472
-39% -$2.87M ﹤0.01% 2222
2021
Q2
$6.9M Buy
120,292
+51,844
+76% +$2.85M ﹤0.01% 2081
2021
Q1
$2.48M Buy
68,448
+9,793
+17% +$450K ﹤0.01% 2519
2020
Q4
$1.97M Buy
58,655
+4,429
+8% +$131K ﹤0.01% 2521
2020
Q3
$1.48M Buy
54,226
+1,804
+3% +$47.3K ﹤0.01% 2501
2020
Q2
$1.42M Sell
52,422
-23,878
-31% -$447K ﹤0.01% 2472
2020
Q1
$1.12M Buy
+76,300
New +$1.28M ﹤0.01% 2469

Other funds holding MORF

Nuveen's MORF Position: Q3 2024 in Review

Nuveen sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 131,695 shares — an estimated $4.49M sold.

Nuveen first reported a position in MORF in Q1 2020 and held it in 18 quarters. The position peaked at $12.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

  • Nuveen reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Nuveen sold 131,695 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $4.49M.
  • Nuveen first reported a position in Morphic Holding, Inc. Common Stock in Q1 2020 and held it in 18 quarters.
  • Nuveen's Morphic Holding, Inc. Common Stock position peaked at $12.4M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.